| 000 | 01975cam a2200313 a 4500 | ||
|---|---|---|---|
| 003 | EG-GiCUC | ||
| 008 | 150404s2014 ua dh f m 000 0 eng d | ||
| 040 |
_aEG-GiCUC _beng _cEG-GiCUC |
||
| 041 | 0 | _aeng | |
| 049 | _aDeposite | ||
| 097 | _aPh.D | ||
| 099 | _aCai01.12.04.Ph.D.2014.Mo.E | ||
| 100 | 0 | _aMohammed Mahmoud Fathy Ahmed | |
| 245 | 1 | 0 |
_aEnhancement of the therapeutic efficacy of anticancer drug using magnetic gold nanocarriers / _cMohammed Mahmoud Fathy Ahmed ; Supervised Wafaa A. Khlial , Nihal S. Elbialy |
| 246 | 1 | 5 | _aتحسين الكفاءة العلاجية للعقار المضاد للأورام بإستخدام جزيئات الذهب المغناطيسية النانومترية كحاملات للعقاقير |
| 260 |
_aCairo : _bMohammed Mahmoud Fathy Ahmed , _c2014 |
||
| 300 |
_a110 P. : _bcharts , facsimiles ; _c25cm |
||
| 502 | _aThesis (Ph.D.) - Cairo University - Faculty of Science - Department of Biophysics | ||
| 520 | _aTreatment of approximately 50% of human cancers includes the use of chemotherapy. The major problem associated with chemotherapy is the inability to deliver pharmaceuticals to specific site of the body without inducing normal tissue toxicity. Consequently, the efficiency of chemotherapy could potentially be improved by the development of a targeted drug nanocarriers that would enhance the effective water solubility of hydrophobic anticancer drugs as well as the selective delivery of drugs to malignant tissues. Thereby increasing the curative effectiveness of the cancer treatment while sparing normal tissues from the side effects of the chemotherapeutic agent | ||
| 530 | _aIssued also as CD | ||
| 653 | 4 | _aDoxorubicin | |
| 653 | 4 | _aMagnetic targeted drug delivery (MTD | |
| 653 | 4 | _aNanoparticles | |
| 700 | 0 |
_aNihal Elbialy , _eSupervisor |
|
| 700 | 0 |
_aWafaa A. Khlial , _eSupervisor |
|
| 905 |
_aNazla _eRevisor |
||
| 905 |
_aSoheir _eCataloger |
||
| 942 |
_2ddc _cTH |
||
| 999 |
_c50268 _d50268 |
||